Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| FUSION ANTIBODIES PLC | 234,700 | net | 09 Sept 2024 | tx 5+263,575−28,875 |
| Fusion Antibodies PLC Ordinary Shares | 200,000 | net | 20 Dec 2018 | tx 1+200,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Sept 2024 | PURCHASE | FUSION ANTIBODIES PLC | 94,825 | — | first after silence |
| 09 Jun 2023 | PURCHASE | FUSION ANTIBODIES PLC | 68,750 | 0.07 GBP | |
| 15 Sept 2022 | PURCHASE | FUSION ANTIBODIES PLC | 100,000 | 0.47 GBP | first after silence |
| 22 Jan 2021 | SALE | FUSION ANTIBODIES PLC | 8,875 | 1.24 GBP | |
| 03 Feb 2020 | SALE | FUSION ANTIBODIES PLC | 20,000 | 0.82 GBP | |
| 20 Dec 2018 | PURCHASE | Fusion Antibodies PLC Ordinary Shares | 200,000 | 0.55 GBP |
2 purchases reported after at least 12 months of silence — most recent on 09 Sept 2024.